Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.5185
-0.0014 (-0.27%)
At close: Jul 1, 2026, 4:00 PM EDT
0.4903
-0.0282 (-5.44%)
After-hours: Jul 1, 2026, 5:40 PM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $1.66 million as of July 1, 2026. Its market cap has decreased by -49.61% in one year.
Market Cap
1.66M
Enterprise Value
11.36M
1-Year Change
-49.61%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $1.66M, a decrease of -96.55%. That is a compound annual growth rate of -51.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 1.66M | -54.68% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.20% |
| Dec 29, 2023 | 2.64M | -57.38% |
| Dec 30, 2022 | 6.19M | -83.57% |
| Dec 31, 2021 | 37.69M | -21.62% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CDT Equity | 3.09M |
| VivoSim Labs | 2.98M |
| Decoy Therapeutics | 2.94M |
| Azitra | 2.70M |
| Oragenics | 2.65M |
| Bone Biologics | 2.51M |
| Virax Biolabs Group | 2.48M |
| Biodexa Pharmaceuticals | 2.18M |